The Scientific Advisory Team at Elevation Oncology provides expert guidance on genomic testing and drug development strategies, ensuring that the company’s therapeutics are precisely targeted to inhibit specific alterations driving cancer growth. Their insights help shape research direction, clinical trial design, and the overall impact of the company’s efforts in precision oncology.